|
| 36928921 | A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. | Clin Cancer Res | 2023 |
| 37276510 | Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study. | Blood Adv | 2023 |
| 36572998 | Non-pathogenic microbiota accelerate age-related CpG Island methylation in colonic mucosa. | Epigenetics | 2023 |
| 36797759 | DNA methylation entropy as a measure of stem cell replication and aging. | Genome Biol | 2023 |
| 36764492 | TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype. | Gastroenterology | 2023 |
| 36658621 | Hypomethylation in MTNR1B: a novel epigenetic marker for atherosclerosis profiling using stenosis radiophenotype and blood inflammatory cells. | Clin Epigenetics | 2023 |
| 36219239 | Epigenome-Wide Study Identifies Epigenetic Outliers in Normal Mucosa of Patients with Colorectal Cancer. | Cancer Prev Res (Phila) | 2022 |
| 35507690 | Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy. | Blood | 2022 |
| 35373289 | The Two-Hit Hypothesis Meets Epigenetics. | Cancer Res | 2022 |
| 35884401 | Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells. | Cancers (Basel) | 2022 |
| 36222848 | Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine. | Clin Cancer Res | 2022 |
| 31451749 | Gestational high fat diet protects 3xTg offspring from memory impairments, synaptic dysfunction, and brain pathology. | Mol Psychiatry | 2021 |
| 33514726 | Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. | Nat Commun | 2021 |
| 34209564 | The Roles of DNA Demethylases in Triple-Negative Breast Cancer. | Pharmaceuticals (Basel) | 2021 |
| 34022936 | Accelerated aging in normal breast tissue of women with breast cancer. | Breast Cancer Res | 2021 |
| 33220403 | High folic acid intake increases methylation-dependent expression of Lsr and dysregulates hepatic cholesterol homeostasis. | J Nutr Biochem | 2021 |
| 33452255 | Cellular Heterogeneity-Adjusted cLonal Methylation (CHALM) improves prediction of gene expression. | Nat Commun | 2021 |
| 32398127 | Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis. | Clin Epigenetics | 2020 |
| 30784602 | Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. | Cell Rep | 2019 |
| 31767039 | DNA methylation aging clocks: challenges and recommendations. | Genome Biol | 2019 |
| 31331399 | Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia. | Clin Epigenetics | 2019 |
| 30833613 | Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant Isolate. | Sci Rep | 2019 |
| 31060979 | Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. | Lancet Haematol | 2019 |
| 30753828 | Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf<sup>V600E</sup>-Induced Tumorigenesis. | Cancer Cell | 2019 |
| 28836271 | Roadmap for investigating epigenome deregulation and environmental origins of cancer. | Int J Cancer | 2018 |
| 29891505 | TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. | Cancer Res | 2018 |
| 29875269 | Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root Ganglion. | J Neurosci | 2018 |
| 30454645 | Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer. | Cell | 2018 |
| 29556023 | Demethylator phenotypes in acute myeloid leukemia. | Leukemia | 2018 |
| 29211308 | Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia. | Cancer | 2018 |
| 29224148 | Digital Restriction Enzyme Analysis of Methylation (DREAM). | Methods Mol Biol | 2018 |
| 28074068 | A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome. | Leukemia | 2017 |
| 28412585 | The promise of epigenetic therapy: reprogramming the cancer epigenome. | Curr Opin Genet Dev | 2017 |
| 28159832 | DNA Hypomethylating Drugs in Cancer Therapy. | Cold Spring Harb Perspect Med | 2017 |
| 28115406 | Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. | Cancer Epidemiol Biomarkers Prev | 2017 |
| 29242551 | Ezh2 phosphorylation state determines its capacity to maintain CD8<sup>+</sup> T memory precursors for antitumor immunity. | Nat Commun | 2017 |
| 28912502 | Caloric restriction delays age-related methylation drift. | Nat Commun | 2017 |
| 28531272 | A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer. | Nucleic Acids Res | 2017 |
| 28926424 | Introduction: Cancer as an Epigenetic Disease. | Cancer J | 2017 |
| 28926426 | Epigenetics and Precision Oncology. | Cancer J | 2017 |
| 28844816 | Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. | Lancet Oncol | 2017 |
| 27879268 | Transcriptional Selectivity of Epigenetic Therapy in Cancer. | Cancer Res | 2017 |
| 27980103 | Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome. | Mol Cancer Ther | 2017 |
| 27022771 | Diet, Nutrition, and Cancer Epigenetics. | Annu Rev Nutr | 2016 |
| 26480922 | Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia. | Leuk Lymphoma | 2016 |
| 27629931 | Targeting the cancer epigenome for therapy. | Nat Rev Genet | 2016 |
| 27542211 | Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin. | Oncotarget | 2016 |
| 26890396 | Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. | Epigenetics | 2016 |
| 26719529 | Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer. | Cancer Res | 2016 |
| 26712470 | Zebrafish embryos as a screen for DNA methylation modifications after compound exposure. | Toxicol Appl Pharmacol | 2016 |